Axiom Catalyst

Follow Axiom Catalyst
Share on
Copy link to clipboard

Axiom Catalyst is your go-to for Life Sciences updates, news, and discussion. We will also feature guest speakers to comment on newsworthy developments. Powered by Axiom Healthcare Strategies, and hosted by Hafiz Sikder and Mahim Misra.

Axiom Healthcare Strategies


    • Sep 29, 2023 LATEST EPISODE
    • infrequent NEW EPISODES
    • 19m AVG DURATION
    • 23 EPISODES


    Search for episodes from Axiom Catalyst with a specific topic:

    Latest episodes from Axiom Catalyst

    Gynecologic Cancer Awareness Month Special

    Play Episode Listen Later Sep 29, 2023 15:49


    Severe care disparities, barriers to diagnosis, harrowing patient stories, historically low survival… and yet… enduring hope for women worldwide.While significant progress has been made to address needs of women with gynecologic cancers, and the last 12 month have seen huge strides in advancing standards of care, key challenges remain including the inclusivity of clinical studies, asymmetric engagement and awareness across communities, and limited ability to tailor therapies, especially in later lines as care options dry up.In this this Gynecologic Cancer Awareness Month special episode of Axiom Catalyst, Dan Simpson, Carlie Darefsky, Harish Venkatesan and Flannery Nania talk through the challenges and hope for patients, as we look to the healthcare industry to raise the bar on health standards.This short podcast complements the specific infographics the Axiom team developed to highlight specific needs and challenges in cervical, ovarian and endometrial cancers respectively. Let's keep raising awareness and saving lives! 

    Duchenne Muscular Dystrophy: Dr. Han Phan on the changing treatment landscape

    Play Episode Listen Later Jun 2, 2023 28:32


    Dr. Han Phan is a member of the Pediatric Advisory Board at the FDA, and the Director of Rare Disease Research center. She joins the Axiom Table with Akash Bhattacharjee. This discussion goes though her experience with diagnosing and treating Duchenne patients, challenges faced by manufacturers in this space, and one of the most eagerly anticipated news of the year in Pharma. 

    ALS Awareness Month: Dr Tim Williams on ALS/MND from physician's perspective

    Play Episode Listen Later May 11, 2023 31:30


    May is ALS Awareness Month and this year Axiom is marking it with a dedicated podcast to help raise awareness about amyotrophic lateral sclerosis (ALS) also known as motor neuron disease. ALS is fatal with the average life expectancy after diagnosis being two to five years, although some patients may live for years or decades. There is still no known cure for ALS and current treatment options primarily target symptoms to improve quality of life, rather than stopping the disease progression. In this episode of Axiom Catalyst, Anna Graca is speaking with Dr Tim Williams from the Newcastle MND Care and Research Centre about how this devastating disease affects each individual differently and tremendous efforts of treating physicians and care coordinators to provide a personalised support to these patients and their families. 

    Rare Neurological Diseases: Frédéric Destrebecq on the importance of building a consensus among key stakeholders

    Play Episode Listen Later Apr 19, 2023 21:26


    There are~ 30 million people in Europe alone living with a rare condition, of which 75% have neurological symptoms. While significant progress has been made to address needs of these patients, key challenges remain including the scarcity of the expertise and fragmentation of research efforts that translate into delayed diagnosis, few disease modifying therapies, and difficulty in accessing adequate care. In this episode of Axiom Catalyst, we invited Frédéric Destrebecq, the Executive Director of the European Brain Foundation and European Brain Council to discuss how coordinated efforts between patient organisations, research and clinical networks, drug innovators and policy makers, can tackle these challenges and reduce the high burden posed by rare neurological disorders in Europe and beyond.

    Sickle Cell Disease: John James sharing patient perspectives

    Play Episode Listen Later Apr 11, 2023 31:11


    While significant therapeutic advances are underway for inherited blood disorders such as sickle cell disease, hemophilia and β-thalassemia, key challenges remain for the commercialization of these therapies, as well as disparities in access to these treatments and level of care received by patients. In this episode of Axiom Catalyst, we invited John James, CEO of Sickle Cell Society to discuss the impact of sickle celldisease on day-to-day lives of patients living in the UK, as well as current challenges in their clinical journey. We also explore the outreach work done by the Sickle Cell Society including key local initiatives such as the Hackney engagement project, and the translatory impact of their patient support work.

    Post ASCO GU 2023

    Play Episode Listen Later Feb 28, 2023 27:30


    Join Nicole, Kiana, and Madelyn's discussion on updates seen at ASCO GU 2023. We analyze some of the most anticipated read outs in RCC, bladder, and prostate cancers and consider what this data means for physicians and patients.

    rcc asco gu
    Bispecifics vs. CAR-Ts in Heme Cancers

    Play Episode Listen Later Feb 11, 2023 24:42


    Join Justin, Rodrigo and Eriko's discussion on bispecific antibody and CAR-T therapies. These innovative options are increasingly becoming available in late-line treatments for heme cancers. In this episode, we cover the advantages and disadvantages of bispecific and CAR-T treatments, emerging CRS considerations, as well as future directions for both modalities in how they pertain to myeloma and lymphoma treatment.

    Post ASCO GI 2023

    Play Episode Listen Later Feb 1, 2023 16:28


    Join Mahim, Samy, & Aman on exciting updates following the ASCO Gastrointestinal Cancers Symposium data readouts as we start 2023 with some exciting updates. In this episode, we share the latest news following recent approvals, 3-year data readouts, and developments in Gastrointestinal, Pancreatic, Colorectal, Hepatocellular Carcinoma, and Biliary Tract Cancer.

    The Latest in Gynecologic Oncology

    Play Episode Listen Later Jan 9, 2023 12:10


    Join Mahim and Allegra's discussions on the latest developments in gynecologic oncology as we wrap up 2022 and enter into the new year. In this episode, we recap the impact of antibody drug-conjugate approvals in cervical and ovarian cancers, new PARP inhibitor data in ovarian cancer, and exciting immunotherapy results in frontline endometrial cancer.

    Gamma Delta Inspired Therapies with Anne Cherry

    Play Episode Listen Later Nov 23, 2022 16:18


    In collaboration with Nick Gherardin from University of Melbourne, and Hafiz, Anne has recently co-authored a review article in Frontiers in Oncology about the novel clinical strategies companies are taking to bring gamma delta-inspired therapies to the clinic. Anne Cherry joins the Axiom Catalyst with Mahim Misra to discuss her paper and some of the exciting developments in gamma delta inspired therapies.

    Dr. John Tsai on Leadership and the Future of BioPharma

    Play Episode Listen Later Nov 18, 2022 22:22


    Dr. John Tsai, former President of Global Drug Development and CMO of Novartis, joins the Axiom Table with Hafiz Sikder. The conversation spans the changing landscape of Immuno-Oncology, AI, and the impact of COVID-19.

    tRNA, Innovation, and Disruption with Michelle Werner

    Play Episode Listen Later Sep 28, 2022 13:37


    Michelle Werner, CEO Partner of Flagship Pioneering and CEO of Alltrna, joins Hafiz Sikder to discuss her work and role at Alltrna as well as her personal investment in the field. She dives deep into the impact of tRNA on drug development, premature stop codons, and her drive to do more for rare disease.

    Live From the Congress floor, ESMO 2022: RCC

    Play Episode Listen Later Sep 14, 2022 12:22


    Join us as we discuss the latest developments in RCC coming out of ESMO22. In this episode, we recap the impact of 3 failed checkpoint-based regimen trials within the (neo)adjuvant setting and the first positive triplet data for advanced RCC.

    Live From the Congress floor, ESMO 2022: NSCLC

    Play Episode Listen Later Sep 13, 2022 14:59


    Join us as Rohan and Andrew discuss key takeaways from an impactful ESMO22 in NSCLC. In this episode, we recap the first Phase III data for a KRASG12C inhibitor, long-term follow-up from checkpoint-based regimens, and the first ADC approval in lung.

    Live From the Congress floor, ESMO 2022: Dr. Hope Rugo

    Play Episode Listen Later Sep 12, 2022 28:52


    Dr. Hope Rugo, University of California at San Francisco, joins Hafiz Sikder for an engaging discussion on the world of Breast Cancer. The discussion ranges from key ESMO data, the future of care, and healthcare disparities.

    Pre-ESMO Curtain Raiser

    Play Episode Listen Later Aug 29, 2022 22:13


    Join in this week as we review key data-set from ESMO as well as a deep dive into RCC, lung and pan-tumor discussions. Join in the discussion with your POV, comments, and questions.

    Gustave Roussy

    Play Episode Listen Later Jul 14, 2022 21:09


    Axiom Catalyst is live from Gustave Roussy! Hafiz Sikder joins Dr. Barlesi and the leading cancer treatment team in Villejuif, France for a discussion on the future of oncology.

    france villejuif gustave roussy
    ASCO Snacks, Day 2

    Play Episode Listen Later Jun 6, 2022 9:43


    Live from the congress floor! Join Mahim Misra and Maressa Cumbermack for part 2 of our ASCO Snacks series, a quick download on the day's most exciting events. Axiom Catalyst will record live at the 2022 American Society of Clinical Oncology's Annual Meeting in Chicago.

    ASCO Snacks, Day 1

    Play Episode Listen Later Jun 5, 2022 13:59


    Live from the congress floor! Join Mahim Misra, Charlotte Caine, and Maressa Cumbermack for part 1 of our ASCO Snacks series, a quick download on the day's most exciting events. Axiom Catalyst will record live at the 2022 American Society of Clinical Oncology's Annual Meeting in Chicago.

    Cell and Gene Therapy Discussions

    Play Episode Listen Later May 27, 2022 20:32


    Vicky Kuo, MS, and Rohan Gidvani, PhD, join Hafiz and Mahim this week to discuss cell and gene therapy before ASCO 2022. Tune in for insights on challenges and emerging technologies from the Axiom Table.

    Discussions in Lung Cancer with Dr. Hossein Borghaei

    Play Episode Listen Later May 13, 2022 20:56


    Dr. Hossein Borghaei, Fox Chase Cancer Center, joins Hafiz and Mahim today to discuss updates in TIGIT, Immunotherapy, and more.

    ASCO 2022 Curtain Raiser

    Play Episode Listen Later Apr 30, 2022 16:36


    On Wednesday April 27, ASCO released 2800+ abstract titles spanning all major tumor types. On today's podcast, we will give you a glimpse into some of the impactful abstracts that will be presented at ASCO in June. Topics will range from practice changing Phase III results from ADCs to emerging modalities like CAR-engineered allogeneic γδ T cells.

    Axiom Catalyst Trailer

    Play Episode Listen Later Apr 25, 2022 1:12


    Subscribe to the Axiom Catalyst! We will meet weekly to give you timely, holistic updates in life sciences.

    Claim Axiom Catalyst

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel